- Vascular Overviews Group/Renal Studies Group
Lisa is a Statistical Programmer at the Clinical Trial Service Unit & Epidemiological Studies Unit (CTSU). She completed her degree in Applied Statistics at the University of Plymouth, and is now the statistical programming lead for the ATT (Anti-Thrombotic Trialists’ Collaboration), CTT (Cholesterol Treatment Trialists’ Collaboration) and STT (Stroke Thrombolysis Trialists’ Collaboration) projects within the CTSU’s Vascular Overviews Group. Her research interests focus on cardiovascular disease and large-scale individual participant meta-analyses of randomised studies.
Interpretation of the evidence for the efficacy and safety of statin therapy.
Collins R. et al, (2016), Lancet, 388, 2532 - 2561
Effects of Alteplase for Acute Stroke on the Distribution of Functional Outcomes: A Pooled Analysis of 9 Trials.
Lees KR. et al, (2016), Stroke, 47, 2373 - 2379
Risk of intracerebral haemorrhage with alteplase after acute ischaemic stroke: a secondary analysis of an individual patient data meta-analysis.
Whiteley WN. et al, (2016), Lancet Neurol, 15, 925 - 933
Impact of renal function on the effects of LDL cholesterol lowering with statin-based regimens: a meta-analysis of individual participant data from 28 randomised trials.
Cholesterol Treatment Trialists' (CTT) Collaboration None. et al, (2016), Lancet Diabetes Endocrinol, 4, 829 - 839
Protocol for analyses of adverse event data from randomized controlled trials of statin therapy.
Cholesterol Treatment Trialists' (CTT) Collaboration None., (2016), Am Heart J, 176, 63 - 69